Helmut J F Salzer Thierry Rolling Stefan Schmiedel Eva-Maria Klupp Christoph Lange Harald Seifert
10.3201/eid2201.151298
Emerg Infect Dis
2016 Jan;22(1):134-7.
acinetobacter ursingii maldi-tof bacteria community-acquired bloodstream infection matrix-assisted laser desorption/ionization time-of-flight mass spectrometry person who injects drugs severe sepsis
CC BY
https://pubmed.ncbi.nlm.nih.gov/26689082/
Acinetobacter / pathogenicity Acinetobacter Infections / microbiology Bacteremia / microbiology Community-Acquired Infections / microbiology
Acinetobacter / pathogenicity Acinetobacter Infections / microbiology Bacteremia / microbiology Community-Acquired Infections / microbiology Case Reports Acinetobacter / drug effects Acinetobacter Infections / drug therapy Bacteremia / drug therapy Community-Acquired Infections / drug therapy Female Humans Meropenem Middle Aged Thienamycins / therapeutic use Thienamycins Meropenem
PMC4696709
26689082
Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs
2016